LUCIRA HEALTH INC (LHDX) Stock Analyst Ratings
USA - NASDAQ:LHDX - US54948U1051 - Common Stock
0.4523 USD
-0.11 (-19.23%)
0.405 USD
-0.05 (-10.46%)
ChartMill assigns a Buy % Consensus number of 43% to LHDX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 0.77. This target is 69.14% above the current price.
LHDX was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about LHDX.
In the previous month the buy percentage consensus was at a similar level.
LHDX was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-05-04 | William Blair | Downgrade | Outperform -> Market Perform |
| 2021-04-13 | B of A Securities | Downgrade | Buy -> Underperform |
| 2021-03-02 | William Blair | Initiate | Outperform |
| 2021-03-02 | B of A Securities | Initiate | Neutral |
LUCIRA HEALTH INC / LHDX FAQ
What do analysts expect the price target to be for LUCIRA HEALTH INC (LHDX)?
6 analysts have analysed LHDX and the average price target is 0.77 USD. This implies a price increase of 69.14% is expected in the next year compared to the current price of 0.4523.
What is the consensus rating for LUCIRA HEALTH INC (LHDX) stock?
The consensus rating for LUCIRA HEALTH INC (LHDX) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.